LifeMD (LFMD) Set to Announce Quarterly Earnings on Thursday

LifeMD (NASDAQ:LFMD) will announce its earnings results after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of ($0.09) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

LifeMD (NASDAQ:LFMD) last posted its earnings results on Wednesday, August 7th. The company reported ($0.19) EPS for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.06). The firm had revenue of $50.66 million during the quarter, compared to analysts’ expectations of $48.47 million. During the same quarter in the previous year, the business earned ($0.23) EPS. On average, analysts expect LifeMD to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

LifeMD Price Performance

NASDAQ:LFMD opened at $4.46 on Wednesday. LifeMD has a 52 week low of $3.99 and a 52 week high of $12.88. The company has a quick ratio of 0.83, a current ratio of 0.87 and a debt-to-equity ratio of 10.83. The stock has a market capitalization of $192.09 million, a PE ratio of -6.37 and a beta of 1.23. The stock’s 50-day moving average price is $4.83 and its 200-day moving average price is $6.67.

Analyst Ratings Changes

A number of equities research analysts have recently commented on LFMD shares. B. Riley started coverage on LifeMD in a research report on Friday, August 23rd. They set a “buy” rating and a $11.00 target price on the stock. Cantor Fitzgerald reiterated an “overweight” rating and issued a $15.00 price objective on shares of LifeMD in a report on Friday, September 20th. Finally, KeyCorp lowered their price objective on LifeMD from $12.00 to $10.00 and set an “overweight” rating on the stock in a report on Thursday, July 11th. Six research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, LifeMD has a consensus rating of “Buy” and an average price target of $12.00.

About LifeMD

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.